These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26246997)

  • 1. Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents.
    Russo F; Gising J; Åkerbladh L; Roos AK; Naworyta A; Mowbray SL; Sokolowski A; Henderson I; Alling T; Bailey MA; Files M; Parish T; Karlén A; Larhed M
    ChemistryOpen; 2015 Jun; 4(3):342-62. PubMed ID: 26246997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of New
    Almeleebia TM; Shahrani MA; Alshahrani MY; Ahmad I; Alkahtani AM; Alam MJ; Kausar MA; Saeed A; Saeed M; Iram S
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33923734
    [No Abstract]   [Full Text] [Related]  

  • 3. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.
    Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA
    mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD
    Wang X; Ahn YM; Lentscher AG; Lister JS; Brothers RC; Kneen MM; Gerratana B; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4426-4430. PubMed ID: 28827112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.
    Martini MC; Zhang T; Williams JT; Abramovitch RB; Weathers PJ; Shell SS
    J Ethnopharmacol; 2020 Nov; 262():113191. PubMed ID: 32730878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
    Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
    J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclic Peptides that Selectively Inhibit the
    Zhang H; Hsu HC; Kahne SC; Hara R; Zhan W; Jiang X; Burns-Huang K; Ouellette T; Imaeda T; Okamoto R; Kawasaki M; Michino M; Wong TT; Toita A; Yukawa T; Moraca F; Vendome J; Saha P; Sato K; Aso K; Ginn J; Meinke PT; Foley M; Nathan CF; Darwin KH; Li H; Lin G
    J Med Chem; 2021 May; 64(9):6262-6272. PubMed ID: 33949190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-1,2,4-Dithiazol-3-one compounds as novel potential affordable antitubercular agents.
    Yang J; Pi W; Xiong L; Ang W; Yang T; He J; Liu Y; Chang Y; Ye W; Wang Z; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1424-7. PubMed ID: 23337602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
    Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB
    J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-Replicating M. tuberculosis.
    Palde PB; Bhaskar A; Pedró Rosa LE; Madoux F; Chase P; Gupta V; Spicer T; Scampavia L; Singh A; Carroll KS
    ACS Chem Biol; 2016 Jan; 11(1):172-84. PubMed ID: 26524379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of drugs against dormant Mycobacterium tuberculosis.
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S94-S95. PubMed ID: 28043638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Phenylimidazole-Based Inhibitors of the
    Zhan W; Hsu HC; Morgan T; Ouellette T; Burns-Huang K; Hara R; Wright AG; Imaeda T; Okamoto R; Sato K; Michino M; Ramjee M; Aso K; Meinke PT; Foley M; Nathan CF; Li H; Lin G
    J Med Chem; 2019 Oct; 62(20):9246-9253. PubMed ID: 31560200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Inhibition of
    Nandakumar M; Ollodart A; Fleck N; Kapadia NR; Frando A; Boradia V; Smith JL; Chen J; Zuercher WJ; Willson TM; Grundner C
    J Med Chem; 2023 Nov; 66(21):14724-14734. PubMed ID: 37871287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
    Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant
    Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q
    Front Immunol; 2021; 12():796677. PubMed ID: 35003120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A luminescence assay for natural product inhibitors of the Mycobacterium tuberculosis proteasome.
    Gunderwala A; Porter J
    Phytochem Anal; 2016; 27(2):126-32. PubMed ID: 26778282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors.
    Siricilla S; Mitachi K; Wan B; Franzblau SG; Kurosu M
    J Antibiot (Tokyo); 2015 Apr; 68(4):271-8. PubMed ID: 25269459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating
    Srivastava S; Cirrincione KN; Deshpande D; Gumbo T
    Front Pharmacol; 2020; 11():616294. PubMed ID: 33542690
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.